 |
| | Intrathecal Drug Delivery with SynchroMed®
Intrathecal
Drug Delivery with SynchroMed®
A viable alternative to oral opioids, IDD has proven efficacy in intractable
nociceptive pain
patients where other therapies have failed, e.g. when oral analgesics have
not been effective
or cause intolerable side-effects |
Trial before implantation
Trial screening period allows patients to experience treatment and evaluate
effectiveness,
before implantation |
Patient satisfaction
Patient-controlled analgesia allows patients to feel more in control of
the management
of their condition (within physician prescribed parameters) |
|
Optimal
dosing
Programmability allows optimal dose titration post-implant and non-invasive
adjustable
dosing to meet changing patient needs
|
|
